应用
选项
-
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: CL2A-SN-38CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Mouse IgG (PE-Cy5.5)简短描述: pAb; Isotype Control Antibody; Mouse IgG (PE-Cy5.5); Flow Cytometry亚型: Mouse IgG宿主种属: 小鼠(Mouse) 偶联: PE-Cy5.5
-
Mouse IgG2a-kappa (PE-Cy5.5), anti-A29L简短描述: mAb (FG07/4F10); Mouse IgG2a-kappa (PE-Cy5.5) Isotype Control Antibody; Flow Cytometry种属反应性: 病毒(Virus) 亚型: Mouse IgG2a宿主种属: 小鼠(Mouse) 克隆号: FG07/4F10 偶联: PE-Cy5.5
-
CD7 Mouse mAb (PE-Cy5.5)关联靶标: CD7简短描述: mAb (T3-3A1); Mouse anti Human CD7 Antibody (PE-Cy5.5); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: T3-3A1 偶联: PE-Cy5.5
-
Mouse IgG1-kappa (PE-Cy5.5), anti-E8L简短描述: mAb (EF12/6D11); Mouse IgG1-kappa (PE-Cy5.5) Isotype Control Antibody; Flow Cytometry种属反应性: 病毒(Virus) 亚型: Mouse IgG1宿主种属: 小鼠(Mouse) 克隆号: EF12/6D11 偶联: PE-Cy5.5
-
Mouse IgG2b-kappa (PE-Cy5.5), anti-E8L简短描述: mAb (EF11/6E10); Mouse IgG2b-kappa (PE-Cy5.5) Isotype Control Antibody; Flow Cytometry种属反应性: 病毒(Virus) 亚型: Mouse IgG2b宿主种属: 小鼠(Mouse) 克隆号: EF11/6E10 偶联: PE-Cy5.5
-
Recombinant CD14 Antibody (PE-Cy5.5)关联靶标: CD14简短描述: Recombinant (P02C06); Mouse anti Human CD14 Antibody (PE-Cy5.5); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG2a宿主种属: 小鼠(Mouse) 克隆号: P02C06 偶联: PE-Cy5.5
-
Recombinant HLA-DR Antibody (PE-Cy5.5)关联靶标: HLA-DRA简短描述: Recombinant (P22B24); Mouse anti Human HLA-DR Antibody (PE-Cy5.5); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG2a宿主种属: 小鼠(Mouse) 克隆号: P22B24 偶联: PE-Cy5.5
-
Recombinant CD14 Antibody (PE-Cy5.5)关联靶标: CD14简短描述: Recombinant (P25A37); Mouse anti Human CD14 Antibody (PE-Cy5.5); Flow Cytometry种属反应性: 人(Human) 亚型: Mouse IgG2a宿主种属: 小鼠(Mouse) 克隆号: P25A37 偶联: PE-Cy5.5
-
Rat IgG (PE-Cy5.5)简短描述: pAb; Isotype Control Antibody; Rat IgG (PE-Cy5.5); Flow Cytometry亚型: Rat IgG宿主种属: 大鼠(Rat) 偶联: PE-Cy5.5
首页
400-620-6333









